share_log

HC Wainwright & Co. Maintains Buy on Cullinan Oncology, Lowers Price Target to $29

Moomoo 24/7 ·  Apr 17 05:36

HC Wainwright & Co. analyst Edward White maintains Cullinan Oncology (NASDAQ:CGEM) with a Buy and lowers the price target from $34 to $29.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment